Novo Nordisk’s Karsten Munk Knudsen is targeting 800 million obese people globally. Read More
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs

Novo Nordisk’s Karsten Munk Knudsen is targeting 800 million obese people globally. Read More